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seems to be a helpful parameter for assessing the degrees of hypercoagulability. Higher
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risk of recurrent ischemic stroke was found to be associated with baseline elevated Ddimers levels. Aim: To assess the value of D-Dimer examination in prediction of
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presence of LA thrombus in patients with AF instead of transesophageal
echocardiography (TEE) examination. Patients and Methods: Analytical crosssectional study was conducted. It included 250 patients divided according to presence of
LA thrombus into two groups; group without LA thrombus (n=224), and group with LA
thrombus (n=26), referred to cardiology department, Mansoura Specialized Medicine
Hospital. History was taken, blood was collected for D-dimer testing on the same day of
the TEE. Results: CHADS2-VASc, Heart failure, Diastolic dysfunction, D-dimers
(ng/mL), D Dimer more than 500 ng/mL, and D Dimer more than 10×patient’s age have
positive and statistically significant impact on LA thrombus formation. Similarly,
Paroxysmal AF and left ventricle ejection fraction (%) had negative and statistically
significant impact on LA thrombus formation. The optimal cutoff point of D-dimers was
1247.9 (ng/mL), its accuracy was 86.4%, (AUC = 0.711) with sensitivity (50%) and
specificity (90.6%). Conclusion: D-dimer can be beneficial in clinical practice to
exclude LA thrombus avoiding TEE, particularly in patients with low thromboembolic
risk such as normal left atrial dimensions, no previous attacks of AF, no valvular heart
disease, female patient, CHAD2VASC score less than 2 and no history of
thromboembolic attacks.
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Introduction
Atrial fibrillation (AF) is that the most

minimize the thromboembolic risk in AF lasting

typical sustained cardiac disturbance all over the

Pre cardioversion TEE is a sensitive

world

(1).

It

is

an

electrocardiographic

for >48 hours (8).

approach for detecting intracardiac thrombus

(5)

,

documentation of irregular RR intervals and not

which usually originates in the left atrial

noticeable, distinct P waves lasting for at least 30 s

appendage , visualization of LA thrombus is

(2).

estimated to range between 8.5% and 12% (9).

It is the most common cause responsible for

supraventricular arrhythmia and one of the main

Although,

TEE

is

a

semi-invasive

causes of cardioembolic stroke (3). As, it increases

technique, it has several disadvantages and risks to

the risk of left atrial thrombus (LAT), and is the

the patient, as it depends on the operator,

main source of emboli (>90%) in patients with

potentially incurs esophageal lesions, and can

nonvalvular AF

(4).

Thrombus

result in transmission of infectious disease by
is

formed

due

to

the

droplets and aerosols can occur (10).

disorganized atrial electrical activity, this results in

Though, there's no identified laboratory

an ineffective contraction and blood stasis,

test that help the diagnosing of left atrial thrombus

especially in the left atrial appendage

(5)

, which is

(LAT), Plasma fibrin D-dimers seems to be a

the main source of thrombus in patients with

helpful parameter for assessing the degrees of

valvular and nonvalvular AF. The other two

hypercoagulability. They can be considered as

components of Virchow’s triad for thrombogenesis

biological markers of coagulation activation and

(endocardial injury and hypercoagulability) also

fibrinolysis, and their presence might indicate

play an important role in the thrombus formation,

thromboembolic phenomena, such as pulmonary

which finally lead to a prothrombotic state in AF

embolism (PE), DVT, acute coronary syndrome or

(6).

aortic dissection (11).
Cardioembolic stroke is one of the most

Because the D-dimer is derived from the

significant complications of AF because it can

cleavage of cross-linked fibrin reflecting both

result in increasing morbidity, mortality and

thrombin production and activation of fibrinolysis,

(7)

disability rates .

its elevated levels may occur in all diseases that

In AF patients, electrical cardioversion has

included an activation of the coagulation system

proven to be the most rapid and effective method

such as the inflammatory diseases, cancers or

to restore sinus rhythm back to normal

(8)

.Because

ischemic cardiovascular diseases (12).

of the potentiality of thrombus presence in the left

Higher risk of recurrent ischemic stroke

atrium (LA) in those patients, cardioversion has

was found to be associated with baseline elevated

high thromboembolic risk, which can extended up

d-dimers levels (≥ 2 µg/mL) in patients with AF

to ten days post cardioversion. So, prior to

(13)

cardioversion, efficient anticoagulation therapy for

levels are considered to be an independent

a minimum of three weeks or transesophageal

predictor of the presence of left atrial thrombus in

echocardiography

patients with AF (14).

(TEE)

are

https://mmj.mans.edu.eg/home/vol51/iss3/3
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. Some studies have shown that raised d-dimer
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Levels of D-dimer are increasing with age,

● Study design

thereby decreasing the specificity (Sp) of cut-off

An analytical cross-sectional study design

values, especially if the patients are over 60 years

was carried out in cardiology department at

of age

(15)

. Two

D-dimer cut-offs are usually

Mansoura medical specialized hospital,

250

defined, the fixed standard D-dimer value of 500

consecutive patients with non-valvular AF were

ng/mL, DD500; and age-adjusted D-dimer value

enrolled in the study, they were divided in the

defined as 10 times the patient’s age, DDAge

analysis into two groups according to presence of

(4).

The association between D-dimer levels,

LA thrombus, the first group without LA thrombus

age-adjusted D-dimer and the absence of LA

(n=224), and the second group with LA thrombus

thrombus has not yet been investigated. So, our

(n=26).

study aims to evaluate the diagnostic ability of D-

● Sample Size Justification

dimer cut-off values to exclude the presence of LA

Sample size was calculated using Power

thrombus in patients with AF and to reduce the

Analysis and Sample Size software program

number of TEE examinations showing absence of

(PASS) version 15.0.5 for windows (2017) using

LA thrombus by presenting the D-dimers as a

data published by D. Almorad et al (2021) with the

useful predictive factor.

ability of D-dimer blood concentrations to exclude
left atrial thrombus in patients with atrial

PATIENTS AND METHODS


fibrillation as the primary outcome.
The null hypothesis was considered as the

Study setting and Study population

This study was carried out in the cardiology

inability of D-dimer blood concentrations to

department at Mansoura Specialized Medicine

exclude left atrial thrombus in patients with atrial

Hospital, included 250 patients with non-valvular

fibrillation.
Almorad et al reported the area under the

AF were enrolled in the study from January 2022
till March 2022.

ROC curve to be 0.96 with incidence of left atrial

Inclusion criteria

thrombus 9.2%. A sample size of 250 patients is

Patients with non-valvular AF or flutter.
Exclusion criteria

needed to achieve 80% power (1-β or the
probability of rejecting the null hypothesis when it

1- Age below 18 years or above 90 years,

is false) in the proposed study using an F test with

2- Moderate and severe valvular heart disease,

a significance level (α or the probability of

3- Valvular mechanical prostheses,

rejecting the null hypothesis when it is true) of 5%

4- Aortic aneurysm or dissection,

(14)

5- Presence of ventricular thrombus,

diseased to 10 controls.

6- Pregnancy,

● Data collection tool

7- Active neoplasia, inflammatory disease,

♦ All the studied participants were subjected to:

8- Recent surgery, stroke, deep venous

- History taking: Patient data, including baseline

thrombosis or PE.

demographic characteristics (age and sex), medical

. The ratio between the two groups was: 1

history (hypertension, diabetes mellitus, coronary

Published by Mansoura Medical Journal, 2023

3

Mansoura Medical Journal, Vol. 51 [2023], Iss. 3, Art. 3
157

D Dimer value in prediction of LAA thrombus in patients with AF

heart disease, myocardial infarction, paroxysmal or

vitamin K antagonists and no anticoagulation with

persistent AF, prior stroke or transient ischemic

undetermined onset of arrhythmia (8).

attack (TIA), anticoagulant use prior to reference

TEE was performed either under local

TEE and its type, time between AF attack and

anesthesia or mild sedation and with continuous

cardioversion.

monitoring of blood pressure and oximetry. A 5–7

- Blood was collected for D-dimer testing on the

MHz multiplane probe was used; the images were

same day of the TEE.

assessed by two experienced echocardiographers

- A follow-up visit was scheduled 1 month after

independently.
All TEE operators and assessors were

cardioversion and included a clinical examination
and an ECG.

blinded to the D-dimer values of the patients.

D-dimer testing

Images

were

taken

in

multiple

standard

First, the blood samples were collected in

tomographic planes. LA thrombus was determined

sodium citrate tubes within 24 hours before TEE

as a local, uniform, ultrasound-dense, multiplane

and processed to the lab.

intracavitary structure discrete from the LA wall or

Then, the assay is based on a rapid ELISA,

its appendage pectinate muscle.

whereby latex microspheres are coated with two
anti-D-

dimer

monoclonal

antibodies.

The

Statistical analysis

presence of D-dimer in the samples causes an

IBM’s SPSS statistics (Statistical Package

agglutination of the microparticles, which lead to

for the Social Sciences) for windows (version 26)

increasing the turbidity in the reaction mixture.

was used for statistical analysis of the collected

D-dimer levels were assessed using the
STAÒ

analyzer

range

(Diagnostica

Stago;

data. Shapiro-Wilk test was used to check the
normality of the data distribution.

Asnières, France), and expressed in ng/mL unit.

Normally distributed continuous variables

According to the manufacturers’ instructions, the

were expressed as mean ± SD while categorical

standard ELISA cut-off value was 500 ng/mL.

variables

Age-adjusted D-dimer values are used as
part of an algorithm to exclude PE

(33).

, two D-

dimer cut-offs were demarcated, the fixed standard

and

the

abnormally

distributed

continuous ones was expressed as median and
inter-quartile range or number and percentage (as
appropriate).

D-dimer value of more than 500 ng/mL, and age-

Student t test and Mann-Whitney was used

adjusted D-dimer value was defined to be 10 times

for

the patient’s age.

continuous data respectively. Chi square test was

Transesophageal echography

used for categorical data using the crosstabs

All TEE were performed only according to
the ESC guidelines to exclude LA before
cardioversion, as; anticoagulation duration shorter

normally

and

abnormally

distributed

function. All tests were conducted with 95%
confidence interval.
If needed, bivariate correlations were

than 3 weeks at the time of cardioversion, a time in

assessed

therapeutic range of <70% in patients receiving

correlation coefficient depending on the nature of

https://mmj.mans.edu.eg/home/vol51/iss3/3
DOI: 10.21608/mjmu.2022.132170.1094

using

Pearson’s

or

Spearman’s
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IV. Risk factors of LA thrombus formation.
Table 4 shows univariate regression
analysis of risk factors of LA thrombus formation,

RESULTS

CHADS2-VASc,

Heart

failure,

Diastolic

Two hundred and fifty patients were

dysfunction, D-dimers (ng/mL), D Dimer more

included in this study, they were divided according

than 500 ng/mL, and D Dimer more than

to presence of LA thrombus into two groups, the

10×patient’s age have positive and statistically

first group without LA thrombus (n=224), and the

significant impact on LA thrombus formation.

second group with LA thrombus (n=26).

Similarly, Paroxysmal AF and LVEF (%) had
negative and statistically significant impact on LA

I. Characteristics and history of the studied

thrombus formation. We used the beta coefficient

participants

for each 1 unit increase in D-dimer.

Table (1) shows patient characteristics and

V. Diagnostic profile of D-dimer and its

history of the studied patients divided according to

calculated derivatives for diagnosis of LA

presence of LA thrombus, there was statistically

thrombus presence.

significant difference between the two groups only
regarding paroxysmal AF (p = 0.001).

Table 5 and figure 1, show the diagnostic
profile of D-dimer in diagnosis of LA thrombus
presence the optimal cutoff point of D-dimers was

II. Echo and clinical examination findings of the

1247.9 (ng/mL), its accuracy was 86.4%, (AUC =

studied participants.

0.711) with sensitivity (50%) and specificity

Table (2) shows the Echo and clinical

(90.6%).

examination findings of the studied participants.

When the D Dimer was more than 500

There was statistically significant difference

ng/mL, the accuracy was founded to be 56.4%

between the two studied groups regarding LVEF

with sensitivity (23.8%) and specificity (100%). In

(%) (p = ˂ 0.001), CHADS2-VASc (p = 0.047),

case of D Dimer more than 10×patient’s age, the

Heart failure (p = ˂ 0.001), and Diastolic

accuracy was 70 % with sensitivity (31.2%) and

dysfunction (p = ˂ 0.001)

specificity (100%). The discrepancy between the

III. D-dimer and its calculated derivatives of

PPV of the generated cut off point and the other

the studied patients.

pre-specified cut points (i.e >500 or age adjusted)

Table 3 shows that there was statistically

can be explained that in the current study, about 21

significant difference between the two studied

patients of No LA thrombus group had higher

groups regarding D-dimers (ng/mL) (p = 0.020), D

levels of D dimer than the proposed cut off points

Dimer more than 500 ng/mL (p = 0.001), D Dimer

ranging between 1348 and 2120. These cases

more than 10×patient’s age (p = ˂ 0.001), and

accounted for a fair number of false positive cases

Diastolic dysfunction (p = 0.001).

hence the low PPV. The receiver operating
characteristic (ROC) curve is the plot the trade-off
between the sensitivity and (1-specificity) across a

Published by Mansoura Medical Journal, 2023
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series of cut-off points when the diagnostic test is

accuracy. In fact, cross-tabulation of data was used

continuous or on an ordinal scale (minimum five

for calculation of the diagnostic profile parameters

categories). So there is no value for generating

while ROC curve was used merely for calculation

curves for pre-specified cut-off (I.e, 500), in this

of AUC and visual demonstration.

case likelihood ratio is used to describe the
Table (1) Patient characteristics and history of the studied patients divided according to presence of LA
thrombus:
No LA thrombus (n= 224)
LA thrombus (n= 26)
P
Age (years)
59.83 ± 7.538
60.19 ± 8.348
0.812
Gender
62.1% (139)
42.3% (11)
0.52
Male
37.9% (85)
57.7% (15)
Female
Paroxysmal AF
53.1% (119)
19.2% (5)
0.001
Diabetes
24.1% (54)
7.7% (2)
0.057
Vascular disease
12.9% (29)
19.2% (5)
0.376
History of stroke
4.5% (10)
11.5% (3)
0.124
History of thromboembolic events
1.3% (3)
3.8% (1)
0.335
Antiarrhythmic drugs
18.3% (41)
26.9% (7)
0.291
Beta-blockers
50.4% (113)
42.3% (11)
0.432
Novel oral anticoagulant
39.7% (89)
42.3% (11)
0.800
Vitamin K antagonists
12.1% (27)
11.5% (3)
0.939
Data is expressed as mean and standard deviation or as percentage and frequency. P is significant when ˂
0.05.
Table (2) Echo and clinical examination findings of the studied patients divided according to presence
of LA thrombus:
No LA thrombus (n= 224)
LA thrombus (n= 26)
P
LVEF (%)
61.62 ± 5.370
52.12 ± 8.199
˂ 0.001
LA diameter (mm)
44.78 ± 8.049
46.08 ± 6.945
0.278
CHADS2-VASc
1.96 ± 1.122
2.50 ± 1.304
0.047
Heart failure
20.1% (45)
57.7% (15)
˂ 0.001
Diastolic dysfunction
19.2% (43)
53.8% (14)
˂ 0.001
Ischemic cardiomyopathy
21.4% (48)
23.1% (6)
0.847
Arterial hypertension
67.4% (151)
57.7% (15)
0.321
Mitral regurgitation
6.7% (15)
7.7% (2)
0.849
Aortic stenosis
3.1% (7)
3.8% (1)
0.843
Data is expressed as mean and standard deviation or as percentage and frequency. P is significant when ˂
0.05.
Table (3) D-dimer and its calculated derivatives of the studied patients divided according to presence of
LA thrombus:
No LA thrombus (n= 224)
LA thrombus (n= 26)
P
D-dimers (ng/mL)
614.7 ± 452.3
1236.2 ± 1042.6
0.020
D Dimer more than 500 ng/mL
53.6% (120)
88.5% (23)
0.001
D Dimer more than 10×patient’s age
40.2% (90)
73.1% (19)
0.001
Data is expressed as mean and standard deviation or as percentage and frequency. P is significant when ˂
0.05.

https://mmj.mans.edu.eg/home/vol51/iss3/3
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Table (4) Univariate regression analysis of risk factors of LA thrombus formation:
B
P
Paroxysmal AF
-1.560 0.002
LVEF (%)
-0.296 ˂ 0.001
CHADS2-VASc
0.371 0.026
Heart failure
1.691 ˂ 0.001
Diastolic dysfunction
1.591 ˂ 0.001
D-dimers (ng/mL)
0.002 ˂ 0.001
D Dimer more than 500 ng/mL
1.894 0.003
D Dimer more than 10×patient’s age 1.397 0.003
P is significant when ˂ 0.05.
Table (5) Diagnostic profile of D-dimer and its calculated derivatives for diagnosis of LA thrombus
presence:
D-dimers (ng/mL)
D Dimer more than 500 ng/mL D Dimer more than 10×patient’s age
AUC (95% CI)
0.711 (0.584, 0.839)
0.674 (0.580, 0.769)
0.664 (0.558, 0.771)
P
˂ 0.001
0.004
0.006
Cut off point
1247.9
Youden's index
0.41
Sensitivity
50.0%
88.5%
73.1%
Specificity
90.6%
16.1%
59.8%
PPV
38.2%
46.4%
17.4%
NPV
94.0%
97.2%
95.0%
Accuracy
86.4%
50.8%
61.2%
Positive likelihood
5.33
1.65
1.82
Negative
0.55
0.25
0.45
likelihood
P is significant when ˂ 0.05.

Figure ( 1 ) ROC curve of D-dimer and its calculated derivatives for diagnosis of LA thrombus presence.

pathophysiology of thrombosis is clarified by the

DISCUSSION
Patients with AF have more risk of

alterations in the Virchow’s triad which consists of

thromboembolism and higher D-dimer levels than

blood flow, vascular endothelial injury and

the

hypercoagulability state (16).

patients

with

sinus

rhythm.

Published by Mansoura Medical Journal, 2023
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Due to LA appendage stasis, the blood

may be even theoretically higher. This approach

flow is interrupted in AF patients. This results in

actually

localization of AF-associated intracardiac thrombi

examination before cardioversion and cardiac

in this region in about ninety percent of patients

ablation by using a noninvasive biomarker (1).

(17)

will

reduce

the

number

of

TEE

. The state of LA fibrosis which results from

Previous various studies suggested fixed

prolonged fibrillatory activity can lead to LA

D-dimer cut-offs either alone or with other

dilatation and dysfunction, which is accompanying

parameters to exclude the presence of LA

with increased the risk of thromboembolic

thrombus, with values are variable between 270

occurrence

(18)

. Also, AF is implicated with a

hypercoagulability state
TEE

(19)

should

.

(21, 22)

. However, choosing one

certain value from these studies is challenging due

be

performed

before

cardioversion in order to help in assessing the
existence of LA thrombus

and >1000 ng/mL

(8).

to the lack of specificity of D-Dimers and their
weak specificity and/or PPVs.

TEE examinations

In this study, D-dimers are strongly

can give positive results from 8.5% to 12% in

associated with the presence of LA thrombus,

detection of the presence of LA thrombus prior to

showing significantly different values between

cardioversion for AF (14).

groups. ROC curve analysis confirmed high D-

In our study the diagnostic ability of D-

dimer values to be strongly predictive of the

dimer cut-off values was evaluated to exclude the

presence of LA thrombus. These findings are also

presence of LA thrombus in patients with AF, we

in accordance with previous reports (21).

included 250 patients with non-valvular AF. The

Our results showed that a D-dimer cut-off

study population was divided into two groups in

value 1247.9 is highly efficient in excluding LA

the analysis, group without LA thrombus (n=224),

thrombus, as the ROC analysis revealed the

and the other group with LA thrombus (n=26) in

accuracy of D-dimer values to predict the presence

cardiology department at Mansoura medical

of LA thrombus (AUC = 0.711), corresponds to a

specialized hospital.

Se of 50 % and a Sp of 90.6% for the prediction of

We aimed to reduce the number of TEE

LA thrombus.

showing absence of LA thrombus by providing the

Increased D-dimer levels were associated

D-dimers as a valuable predictive factor. Similar to

with the presence of LA thrombus, which

current literature, our results show elevated D-

recommended that it is a strong discriminant

dimer levels in patients with AF, suggesting it as a

between patient with and without LA thrombus

strong discriminant between patient with and

(20,21)

without LA thrombus (20).

Heart failure, Diastolic dysfunction, LVEF and

We have considered that a D-dimer–based

, in addition to the CHA2DS2-VASc score,

non-paroxysmal AF.

strategy is an effective and safe to decide the need

This value is near to Habara et al where

for TEE to rule out LAT in selected patients with

best cut-off was established at 1150 ng/mL with

AF, especially those

Se/Sp (76%/73%) and NPV of 100%

with a low risk of

thromboembolism, as the negative predictive value

https://mmj.mans.edu.eg/home/vol51/iss3/3
DOI: 10.21608/mjmu.2022.132170.1094

(21)

,

also

close to Almorad et al study, which results show
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elevated D-dimer levels in patients with LA

It is not clear if that the negative predictive value

thrombus than without LA thrombus, as the ROC

of 95% is high enough for D-dimer to be used in

analysis revealed the accuracy of high D-dimer

clinical practice to exclude LAT in patients with

values to predict the presence of LA thrombus

AF, as this decision must be modified according to

(AUC=

the clinical context of each patient.

0.96). A value of 1344 ng/mL

corresponds to a Se of 100% and a Sp of 86% for
the prediction of LA thrombus

(14)

.

The use of age-adjusted D-dimer has been
suggested as an alternative test to the fixed cutoff

And, similar to to previous studies which

of D-dimer because the plasma levels of D-dimer

assessed D-dimer at 500 ng/mL (21, 22,23,24) in which

are increasing with age. The validity of this test

the estimates of sensitivity ranged from 12% to

has been demonstrated in previous studies to

92% and of specificity ranged from 65% to 99%.

exclude acute pulmonary embolism in patients

The AUC was 0.81. Based on a prevalence of LAT

with a low or intermediate low pretest probability

of 10% in patients with AF

(25),

the positive

(26)

.

predictive value and negative predictive value
were 31.6% and 94.1%, respectively.

Dimer more than 500 ng/mL (AUC = 0.674), the

In Meta-analysis of previous studies,

sensitivity was 23.8 % and the specificity was

(21,22,

100%. Age-adjusted D-dimer was assessed, (AUC

The pooled sensitivity and specificity of D

=0.664), the sensitivity was 31.2% and the

regarding the D-dimer at the optimal cutoff
23,24).

Our study results have founded that, D-

dimer at 500 ng/mL to detect LAT in patients with

specificity was 100%.

valvular and nonvalvular AF were founded to be

In two previous studies that assessed age(14,27)

50% and 88%, respectively. The optimum cutoff

adjusted D-dimer

, the sensitivity was 24%

of D-dimer was 390 ng/mL with a pooled

and 52% and the specificity was 99% and 99%.

sensitivity and specificity of 68% and 73%,

The pooled sensitivity and specificity were 36%

respectively. The negative predictive value of D-

(95% CI 14%–66%) and 99% (95% CI 96%–

dimer was high via different cutoffs (390 and 500

99%), respectively. The AUC was 0.99. depending

ng/mL) and age-adjusted D dimer. Numerous

on the prevalence of LAT of 10% in patients with

cutoff points of D-dimer have been previously

AF

evaluated to predict LAT, resulting in diverse

predictive

diagnostic accuracies.

respectively.

(25)

, the positive predictive value and negative
value

were

80%

and

93.3%,

The collective optimal cutoff of D-dimer

There are many clinical characteristics

was founded to be 390 ng/mL with a high negative

(such as CHA2DS2-VASc score, type of AF,

predictive value of 95.4% to dismiss the presence

previous

of thrombus. Likewise, D-dimer at 500 ng/mL,

stenosis) that can impact the existence of LAT in

which is the threshold mostly recommended to

patients with AF (5).

stroke,

anticoagulation,

and

mitral

exclude acute pulmonary embolism in patients

In the present study, with the mean

with low or intermediate pretest probability,

CHA2DS2-VASc score among patients with LA

showed a high negative predictive value (94.1%).

thrombus

Published by Mansoura Medical Journal, 2023

(2.50 ± 1.304)

was

statistically

9

Mansoura Medical Journal, Vol. 51 [2023], Iss. 3, Art. 3
163

D Dimer value in prediction of LAA thrombus in patients with AF

significantly higher than among patients without

(current use of anticoagulation, history of stroke,

LA thrombus (1.96 ± 1.122) (p= 0.047).

and paroxysmal AF) and could potentially be

Similar to Almorad et al study, in which

useful within each subgroup (1).

109 patients (76.7%) had an elevated CHA2DS2-

A previously published meta-analysis has

VASc score (≥2), of which 12 were diagnosed

reported that cardiac computed tomography has a

with LA thrombus by TEE, the difference in

high diagnostic accuracy for excluding the

CHA2DS2-VASc score between patients with and

presence of LAT in patients with AF with a

without LA thrombus was founded to be

negative predictive value of 99% (30) .However, the

significant (p<0.05) (14).

decision of which noninvasive test (D-dimer or

Also, in accordance with previous findings

cardiac computed tomography) is better needs

that showing a relationship between the a priori

studies that compare both tests directly, since the

estimation

through

comparison of the pooled negative predictive

CHA2DS2-VASc score and the actual presence of

values (95% vs 99%), as a result of combining

of

LA thrombus

thromboembolic

risk

(28).

different sets of studies, is not suitable.

Our study results revealed that LVEF (%)

Cardiac

computed

tomography

has

had negative and statistically significant impact on

noteworthy disadvantages when compared with D-

LA thrombus formation. This is similar to

dimer, such as the cost is higher, it requires

Almorad et al study, in which low LVEF was

contrast material, and the exposure to ionizing

significantly more frequent in patients with LA

radiation can be significantly high (31).

thrombus

(14)

, also consistent with the presence of

Our study has some limitations, such as;

heart failure in the calculation of the CHA2DS2-

the rapid ELISA test was used to measure D-dimer

VASc score

(29).

levels. However, with high Sensitivity and

In our study, paroxysmal AF had negative
and

statistically

significant

impact

LA

test can be one of the most greater performing

thrombus formation, similar to Almorad et al study

diagnostic tools available for D-dimer testing.

results which showed that non-paroxsymal patients

Nevertheless; data, conclusions and the cut-off

with AF had higher risk of LA thrombus
In

our

study,

regarding

on

negative predictive value levels, the rapid ELISA

(14)

.

values cannot be extrapolated to techniques other

receiving

than ELISA.

anticoagulation therapy, there was no statistically

Also, many clinical limitations have been

significant difference between the two groups, this

included, these clinical situations can affect D-

was in concordance with Almorad et al study

(14)

in

which of the 83 patients receiving anticoagulation

dimers upwards, which does not impact the NPVs
of the selected thresholds and thus their safety.

therapy, five had a LA thrombus ; however, the

Another limitation of our study is the

difference with patients without LA thrombus was

limited number of patients who included. A larger

found to be not significant.

number of patients can allow a better definition of

In previous meta analyses, the negative

the best cut-off value of D-dimers to measure the

predictive value stills high across subgroups

risk of LA thrombus occurrence. However, the

https://mmj.mans.edu.eg/home/vol51/iss3/3
DOI: 10.21608/mjmu.2022.132170.1094
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lack of specificity will always hinder the

2. Fonseca AC Coelho P. Update on

interpretation of their value.

Biomarkers Associated to Cardioembolic

Our study recommendations are that

Stroke: A Narrative Review. Life. 2021

prospective studies with larger samples assessing

May;11(5):448.

the optimal clinical scenario in which D-dimer

3. Hayden DT, Hannon N, Callaly E, Ní

works best to exclude LAT are still needed, and

Chróinín D, Horgan G, Kyne L, Duggan

whether D-dimer should be used alone or in

J, Dolan E, O’Rourke K, Williams D,

combination with other clinical parameters (such

Murphy S. Rates and Determinants of 5-

as CHA2DS2-VASc score, type of AF, previous

Year Outcomes After Atrial Fibrillation–

stroke,

Related Stroke: A Population Study.

anticoagulation, and

mitral

stenosis)

remains unknown and needs to be further
explored.

Stroke. 2015 Dec;46(12):3488-93.
4. Lin C, Bao Y, Hua W, Zhang N, Jin Q,
Xie Y, Wei Y, Luo Q, Liu Z, Ling T,
Pan W. Differences in D-dimer blood

CONCLUSION
Our study helps to determine the efficacy of

concentration in atrial fibrillation patients

D-dimer cut-off to exclude the presence of a LA

with left atrial thrombus or severe left

thrombus in patients with AF. The plasma levels of

atrial spontaneous echo contrast. Journal

D-dimer were higher in patients with AF and LAT

of

than in patients without thrombus.

Electrophysiology. 2021 May 3:1-7.

The optimal cutoff D-dimer was 1247.9

5. Jame

Interventional

S,

Barnes

G.

Cardiac

Stroke

and

ng/mL with a sensitivity of 50% and a specificity

thromboembolism prevention in atrial

of 90.6 %.

fibrillation.Heart 2020;106:10–17.

Both of D-dimer more than 500 ng/mL and

6. Khan AA, Lip GYH. The prothrombotic

D Dimer more than 10×patient’s age showed high

state

specificity (100%) to exclude LAT. So, D-dimer

pathophysiological

can be beneficial in clinical practice to exclude

implications.

LAT avoiding TEE, particularly in patients with

115:31–45.

low thromboembolic risk.

7.

atrial
and

Cardiovasc

fibrillation:
management
Res

2019;

Hindricks G, Potpara T, Dagres N,
Arbelo
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